Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmadule Morimatsu AB
AB
Active
Org 5568464910
Hästholmsvägen 28, 131 30
Nacka
Engineering activities and related technical consultancy
· NACE 7112
Est. 2011
16 employees
Watchlist
Share
Sweden
/
Companies
/
Engineering activities and related technical consultancy
/
Pharmadule Morimatsu AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
242M
484M
725M
967M
69M
2020
215M
2021
485M
2022
841M
2023
354M
2024
EBITDA
SEK millions
0M
6M
13M
19M
25M
22M
2020
13M
2021
-14M
2022
14M
2023
15M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
68 792
214 877
484 728
841 322
353 594
Staff expenses
—
—
—
—
—
EBITDA
21 613
12 623
−14 368
13 858
14 637
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
21 613
12 623
−14 368
13 858
14 637
Net financials
−34 483
12 054
−117 900
−8 218
−29 916
Profit before tax
17 985
20 277
12 396
22 984
10 633
Tax
−762
−1 971
−2 582
−4 791
−3 145
Net profit
17 223
18 306
9 814
18 193
7 488
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
82 056
275 242
307 578
396 189
620 300
Equity
33 157
51 464
61 278
79 471
53 860
Long-term debt
0
0
0
0
0
Short-term debt
48 899
219 378
237 800
301 218
550 939
Total debt
48 899
219 378
237 800
301 218
550 939
Financial ratios
5-year trend
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
2020
2024
Equity ratio
8.7%
This company
38.2%
Market median
-77% vs market
2020
2024
Return on equity
13.9%
This company
18.4%
Market median
+24% vs market
2020
2024
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
2020
2024
Asset turnover
0.57×
This company
1.12×
Market median
-49% vs market
2020
2024
Debt / equity
10.52×
This company
0.62×
Market median
-1597% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pharmadule Morimatsu AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
